133 related articles for article (PubMed ID: 28252652)
1. BH3 mimetic-elicited Ca
Ferdek PE; Jakubowska MA; Nicolaou P; Gerasimenko JV; Gerasimenko OV; Petersen OH
Cell Death Dis; 2017 Mar; 8(3):e2640. PubMed ID: 28252652
[TBL] [Abstract][Full Text] [Related]
2. Proapoptotic BAX and BAK regulate the type 1 inositol trisphosphate receptor and calcium leak from the endoplasmic reticulum.
Oakes SA; Scorrano L; Opferman JT; Bassik MC; Nishino M; Pozzan T; Korsmeyer SJ
Proc Natl Acad Sci U S A; 2005 Jan; 102(1):105-10. PubMed ID: 15613488
[TBL] [Abstract][Full Text] [Related]
3. Identification of a novel form of caspase-independent cell death triggered by BH3-mimetics in diffuse large B-cell lymphoma cell lines.
Yildirim N; Sarojam L; Smith VM; Pieper NM; Anders M; Jackson RA; Fuhrmann DC; Särchen V; Brücher D; Weigert A; Dyer MJS; Vogler M
Cell Death Dis; 2024 Apr; 15(4):266. PubMed ID: 38622118
[TBL] [Abstract][Full Text] [Related]
4. Restoring Apoptosis with BH3 Mimetics in Mature B-Cell Malignancies.
Jullien M; Gomez-Bougie P; Chiron D; Touzeau C
Cells; 2020 Mar; 9(3):. PubMed ID: 32183335
[TBL] [Abstract][Full Text] [Related]
5. Platelet-derived growth factor primes cancer-associated fibroblasts for apoptosis.
Ilyas SI; Mertens JC; Bronk SF; Hirsova P; Dai H; Roberts LR; Kaufmann SH; Gores GJ
J Biol Chem; 2014 Aug; 289(33):22835-22849. PubMed ID: 24973208
[TBL] [Abstract][Full Text] [Related]
6. The structural basis of Bcl-2 mediated cell death regulation in hydra.
Banjara S; D Sa J; Hinds MG; Kvansakul M
Biochem J; 2020 Sep; 477(17):3287-3297. PubMed ID: 32776134
[TBL] [Abstract][Full Text] [Related]
7. Mitophagy Promotes Resistance to BH3 Mimetics in Acute Myeloid Leukemia.
Glytsou C; Chen X; Zacharioudakis E; Al-Santli W; Zhou H; Nadorp B; Lee S; Lasry A; Sun Z; Papaioannou D; Cammer M; Wang K; Zal T; Zal MA; Carter BZ; Ishizawa J; Tibes R; Tsirigos A; Andreeff M; Gavathiotis E; Aifantis I
Cancer Discov; 2023 Jul; 13(7):1656-1677. PubMed ID: 37088914
[TBL] [Abstract][Full Text] [Related]
8. DRP-1 functions independently of mitochondrial structural perturbations to facilitate BH3 mimetic-mediated apoptosis.
Milani M; Beckett AJ; Al-Zebeeby A; Luo X; Prior IA; Cohen GM; Varadarajan S
Cell Death Discov; 2019; 5():117. PubMed ID: 31341643
[TBL] [Abstract][Full Text] [Related]
9. A p53 score derived from TP53 CRISPR/Cas9 HMCLs predicts survival and reveals a major role of BAX in the response to BH3 mimetics.
Durand R; Descamps G; Bellanger C; Dousset C; Maïga S; Alberge JB; Derrien J; Cruard J; Minvielle S; Lilli NL; Godon C; Le Bris Y; Tessoulin B; Amiot M; Gomez-Bougie P; Touzeau C; Moreau P; Chiron D; Moreau-Aubry A; Pellat-Deceunynck C
Blood; 2024 Mar; 143(13):1242-1258. PubMed ID: 38096363
[TBL] [Abstract][Full Text] [Related]
10. Putting the STING back into BH3-mimetic drugs for TP53-mutant blood cancers.
Diepstraten ST; Yuan Y; La Marca JE; Young S; Chang C; Whelan L; Ross AM; Fischer KC; Pomilio G; Morris R; Georgiou A; Litalien V; Brown FC; Roberts AW; Strasser A; Wei AH; Kelly GL
Cancer Cell; 2024 May; 42(5):850-868.e9. PubMed ID: 38670091
[TBL] [Abstract][Full Text] [Related]
11. Structural transition in Bcl-xL and its potential association with mitochondrial calcium ion transport.
Rajan S; Choi M; Nguyen QT; Ye H; Liu W; Toh HT; Kang C; Kamariah N; Li C; Huang H; White C; Baek K; Grüber G; Yoon HS
Sci Rep; 2015 May; 5():10609. PubMed ID: 26023881
[TBL] [Abstract][Full Text] [Related]
12. Initiation of apoptosis and autophagy by the Bcl-2 antagonist HA14-1.
Kessel D; Reiners JJ
Cancer Lett; 2007 May; 249(2):294-9. PubMed ID: 17055152
[TBL] [Abstract][Full Text] [Related]
13. Promotion of PDT efficacy by a Bcl-2 antagonist.
Kessel D
Photochem Photobiol; 2008; 84(3):809-14. PubMed ID: 18179619
[TBL] [Abstract][Full Text] [Related]
14. Mitochondrial bioenergetics as a cell fate rheostat for responsive to Bcl-2 drugs: New cues for cancer chemotherapy.
Palominos C; Fuentes-Retamal S; Salazar JP; Guzmán-Rivera D; Correa P; Mellado M; Araya-Maturana R; Urra FA
Cancer Lett; 2024 May; 594():216965. PubMed ID: 38788967
[TBL] [Abstract][Full Text] [Related]
15. Molecular-Scale Investigations Reveal the Effect of Natural Polyphenols on BAX/Bcl-2 Interactions.
Sun H; Liao F; Tian Y; Lei Y; Fu Y; Wang J
Int J Mol Sci; 2024 Feb; 25(5):. PubMed ID: 38473728
[TBL] [Abstract][Full Text] [Related]
16. Calcium waving from the pancreas: the physiological regulation of cytosolic Ca
Bruce JIE
J Physiol; 2023 Jun; 601(12):2231-2232. PubMed ID: 37177867
[No Abstract] [Full Text] [Related]
17. Getting more bang for their buck: BCL2 inhibitors boost dendritic-cell function to enhance anti-cancer immune surveillance.
Montes-Gómez AE; Tait SWG
J Transl Med; 2024 Mar; 22(1):317. PubMed ID: 38549077
[TBL] [Abstract][Full Text] [Related]
18. Moujalled DM, Brown FC, Chua CC, et al. Acquired mutations in BAX confer resistance to BH3-mimetic therapy in acute myeloid leukemia. Blood. 2023;141(6):634-644.
Blood; 2023 Aug; 142(5):494. PubMed ID: 37535365
[No Abstract] [Full Text] [Related]
19. Kinetics of the thapsigargin-induced Ca
Pick T; Gamayun I; Tinschert R; Cavalié A
Front Physiol; 2023; 14():1127545. PubMed ID: 37051019
[TBL] [Abstract][Full Text] [Related]
20. ABT-199 (Venetoclax), a BH3-mimetic Bcl-2 inhibitor, does not cause Ca
Jakubowska MA; Kerkhofs M; Martines C; Efremov DG; Gerasimenko JV; Gerasimenko OV; Petersen OH; Bultynck G; Vervliet T; Ferdek PE
Br J Pharmacol; 2019 Nov; 176(22):4402-4415. PubMed ID: 30266036
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
